Governance

The Network’s governance structures are outlined in its Terms of Reference. Full editorial control over outputs lies with the HFPN secretariat on behalf of the Steering Committee. HFPN outputs are educational and non-promotional, and not subject to legal or scientific review by any sponsor. Sponsors have no right of veto. The HFPN secretariat operates independently in the public domain to deliver the core HFPN mission statement.

Each project is guided by an independent Project Advisory Group (PAG), which reads and comments in depth on drafts and project outputs to ensure all work and activities reflect a broad, multidisciplinary and evidence-based consensus. All members provide their time for free.

Download Terms of Reference
governance graphic

Explore More

About Us Contact Us
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.